Disclaimer: this is not financial advice. This is a Redditor sharing their opinion.

1. Summary

Weave Communications stock has fallen dramatically along with most of the SaaS world, but its moat has definite strengths due to tie-in with critical customer business functionality and hardware leasing/integration. Further, it appears to benefit from AI as much as it is threatened by it. Currently trading around 1X enterprise value/2026E revenue while growing double digits, it has an underappreciated tailwind due to a new ADA partnership. I expect the stock to rise from here over time based on revenue growth and modest multiple expansion paired with somewhat more disciplined capital allocation. My base case has WEAV at $8 by end of 2026 vs. current share price of $4.62. More immediate upside exists if the company goes private in 2026, and recent moves seem to make this path more likely.

2. Business description

Weave Communications (NYSE: WEAV) sells a “front office” operating layer for small and medium-sized healthcare practices, with a product suite spanning communications, scheduling/workflow automation, reputation management, payments, and related productivity tools. The company positions itself as an orchestration layer that unifies voice/text interactions and embeds AI-powered workflows into the day-to-day “patient journey,” integrated with practice management systems (“PMS”). Their top customer base is dental offices.

There are plenty of SaaS companies trading at large historical discounts. The reason I'm especially interested in Weave is they are also a VoIP provider and tightly integrate cloud telephony with its SaaS workflows. The company explicitly describes its platform as combining patient engagement tools with “voice over internet protocol (‘VoIP’) phone services.”

Operationally, Weave is already scaled in SMB healthcare: it ended 2025 with 39,625 customer locations under subscription.

Why the system is fairly sticky

Weave's communications layer is built around the practice’s trusted phone number and a proprietary telephony platform that unifies voice + text.

Its product positioning is very explicit:

• Unified Phone Number: calls and texts come from the trusted practice number so patients save one number and staff can manage conversations seamlessly. * Customized Phone System: a “smarter phone system” that surfaces patient context at the start of each call (caller identity, appointment context, balances, tasks, notes, and follow-ups). * Cloud-based + integrated build: the company says its phone system is built in-house, cloud-based, integrated into the software platform, and uses SIP trunking with multiple providers for voice routing/redundancy.

This matters because (1) practices run their day around inbound calls, (2) patient communication is a “high cost of failure” workflow, and (3) replacing telephony + workflow software is a heavier lift than replacing a single point solution.

Weave’s subscription business is largely month-to-month (with a minority on 1–3 year terms). If Weave were primarily a lightweight reminders/texting layer, month-to-month economics would likely translate into much worse retention than what the company reports.

Instead, the phone system is operationally embedded and comes with real-world switching friction:

• The company flags that onboarding/ramp can be delayed by complications with phone number porting, which works the other way too if the customer decides to switch away from Weave. * Weave also provides phone hardware as part of its subscription bundles; it remains Weave-owned and must be returned if the customer cancels. Typically these are Yealinks or Polycoms (Weave does not design its own phone hardware). * The business is regulated as a VoIP provider (e.g., E-911 frameworks, porting rules), which adds real compliance and operational infrastructure requirements behind the scenes.

Retention data

Weave discloses both dollar-based net revenue retention (NRR) and gross revenue retention (GRR):

• 2025 dollar-based NRR: 93% (vs. 98% in 2024) * 2025 dollar-based GRR: 89% (vs. 91% in 2024)

These rates are calculated using “adjusted monthly revenue” (subscription revenue plus a smoothed contribution from payments), and Weave provides explicit methodology. NRR at 93% is not best-in-class for SMB SaaS, and I consider it a yellow flag (more in Risks). But GRR at 89% still indicates that most locations remain, which is consistent with a product anchored to a practice phone number rather than a superficial communications overlay, especially given month-to-month contracting.

3. Growth drivers and identifiable catalysts

The core bull case is that Weave can keep compounding “locations × ARPU” while layering higher-margin product attach (payments, AI workflows, insurance verification) onto a communications hub that is difficult to rip out.

Product-led drivers already in motion

Weave’s platform integrates with more than 90 PMS systems, positioning it to sit inside scheduling/billing/insurance workflows rather than remain an external comms “bolt-on.”

Two concrete product vectors stand out:

1. AI receptionist / automation via TrueLark Weave acquired TrueLark on May 16, 2025 for total consideration of $35.9 million, and it has tied new AI receptionist functionality to TrueLark. In the 10-K, Weave says it introduced an AI receptionist in 2025 (powered by TrueLark) that follows up on missed calls with interactive AI texting and lets patients book appointments any time. There's opportunity to win new business as a package deal, but there's also a high-margin boost from upselling current Weave customers on TrueLark (priced at $250/month incremental add vs. $475/month average customer price for non-TrueLark Weave). 2. Insurance eligibility with RPA In February 2026, Weave announced “Weave Insurance Eligibility,” emphasizing robotic process automation to pull real-time data from payer portals and citing an “average verification rate of 90%.” This is important because insurance verification is a direct labor/time sink in dental and other specialties, and automating it increases platform value and makes Weave harder to replace.

ADA endorsement

This month, Weave became the exclusive patient engagement platform endorsed for members of the American Dental Association through ADA Member Advantage. The endorsement was publicly reported on March 12–13, 2026. The stock could not have cared less.

However I think this matters a fair bit:

• It creates a distribution wedge into a large, economically attractive customer cohort and comes with co-marketing exposure and member discounts/training. * The endorsement messaging itself emphasizes Weave’s phone system + number, AI receptionist, insurance eligibility, and multi-location enterprise features, i.e., “the phone as a moat” is central even in the ADA’s framing. * I estimate WEAV is installed in ~15% of US dental offices. In other words, it has brand relevance but the installed base is nowhere close to saturated, and this endorsement strengthens credibility as well as reach. Terms are not disclosed from what I can tell but I expect very low-cost customer acquisitions coming out of this.

Channel/integration catalysts: distribution leverage

Dental channel partnerships are a recurring theme. A tangible example is Weave’s partnership announcement with Patterson Dental Supply, Inc. (a subsidiary of Patterson Companies, Inc.): the July 2024 release describes deeper data exchange integrations (read/write patient + appointment data, ledger writeback to facilitate payments) and explicitly notes that Weave’s VoIP phone systems enable features like Call Pop and Practice Analytics. Patterson has ~37k PMS customers and should supply Weave with a steady stream of customers.

Separately, Weave announced it is an authorized integration vendor in the Henry Schein One API Exchange (Dentrix/Dentrix Ascend ecosystem), highlighting secure/stable integrations and workflow-linked features such as call pop–style patient context.

4. Financial profile, unit economics, and valuation

Current financial trajectory

Weave posted $239.0 million of total revenue in 2025 (+17% YoY) and 72.1% GAAP gross margin for the full year. It also generated $17.5 million in cash from operations and $12.9 million in free cash flow for 2025.

For 2026, Weave guided to:

• Full-year revenue: $273.0-$276.0 million * Full-year non-GAAP income from operations: $8.0-$12.0 million

That implies another year of mid-teens revenue growth.

Valuation set-up

As of March 31, 2026, WEAV traded at $4.62, with market cap about $363mm (78.6mm shares outstanding), net cash of $81.7mm and enterprise value about $281.3mm.

Using the midpoint of 2026 revenue guidance ($274.5m), the stock trades at roughly:

• ~1.02x EV / 2026E revenue (281.3 / 274.5)

This is extremely low for a business that is (a) predominantly recurring and (b) growing revenue double digits.

Directional targets

Below is a multiple-based framework using EV/Revenue on 2026 guidance (midpoint), and adding back implied net cash (EV vs market cap). Inputs are from disclosed EV / market cap and company guidance.

|Scenario|EV / 2026E Revenue|EV ($mm)|Implied Price|Upside vs. ~$4.62| |:-|:-|:-|:-|:-| |“No love” (still cheap)|1.5x|412|~$6.28|~+36%| |Valuation normalization|2.0x|549|~$8.02|~+74%| |Re-rate + quality recognition|2.5x|686|~$9.77|~+112%|

A re-rating is plausible but not guaranteed of course. 2026 guidance implies continued growth plus improving non-GAAP operating profitability, and Weave has identifiable distribution catalysts (ADA endorsement; enterprise/multi-location motions; channel integrations).

5. Strategic Optionality

I'm a firm believer in owning companies where I'm okay with the existing ownership structure persisting and that's my assessment of Weave. That said, in th